Personalis Newsroom

Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsNov 19 09:31 ET

Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Raises Target Price to $5

Moomoo NewsNov 19 03:36 ET

Personalis: Promising Growth in Biopharma Sales Amidst Strategic Challenges – Hold Rating Maintained

TipRanksNov 18 20:56 ET

A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $7 to $9

Moomoo NewsNov 8 08:16 ET

H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 7 06:33 ET

Needham Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $7.25

Moomoo NewsNov 7 05:33 ET

Personalis Analyst Ratings

BenzingaNov 7 05:31 ET

Needham Reiterates Buy on Personalis, Maintains $7.25 Price Target

BenzingaNov 7 05:30 ET

Personalis: Strong Revenue Growth and Strategic Advances Justify Buy Rating

TipRanksNov 7 05:29 ET

TD Cowen Maintains Personalis(PSNL.US) With Buy Rating

Moomoo NewsNov 7 00:32 ET

TD Cowen Remains a Buy on Personalis (PSNL)

TipRanksNov 7 00:07 ET

Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsSep 20 09:33 ET

Lake Street Keeps Their Buy Rating on Personalis (PSNL)

TipRanksSep 20 08:49 ET

Personalis (PSNL) Receives a Buy From BTIG

TipRanksAug 21 06:35 ET

BTIG Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 21 06:31 ET

Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsAug 19 09:33 ET

Lake Street Remains a Buy on Personalis (PSNL)

TipRanksAug 19 09:27 ET

TD Cowen Maintains Personalis(PSNL.US) With Buy Rating

Moomoo NewsAug 19 07:31 ET

H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsAug 19 06:31 ET

BTIG Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsAug 16 15:32 ET